# | Title | Journal | Year | Citations |
---|
|
1 | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) | Autophagy | 2016 | 4,789 |
2 | Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 | Cell Death and Differentiation | 2018 | 4,451 |
3 | Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer | New England Journal of Medicine | 2004 | 4,181 |
4 | Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck | New England Journal of Medicine | 2016 | 4,020 |
5 | One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States | Journal of Clinical Oncology | 2008 | 3,948 |
6 | Guidelines for the use and interpretation of assays for monitoring autophagy | Autophagy | 2012 | 3,158 |
7 | Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis | Journal of Clinical Oncology | 2005 | 2,678 |
8 | Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers | Nature Genetics | 1997 | 2,618 |
9 | Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma | Journal of Clinical Oncology | 2001 | 2,473 |
10 | Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer | Journal of Clinical Oncology | 2008 | 2,450 |
11 | Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System | Journal of Clinical Oncology | 2001 | 2,410 |
12 | Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy | Journal of Clinical Oncology | 2004 | 2,345 |
13 | Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial | Lancet Oncology, The | 2009 | 2,177 |
14 | Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical Cancer | New England Journal of Medicine | 1999 | 2,047 |
15 | Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy | Cancer | 2006 | 1,907 |
16 | Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS) | Surgery | 2011 | 1,798 |
17 | Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual | Ca-A Cancer Journal for Clinicians | 2017 | 1,748 |
18 | Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide | Nature | 2007 | 1,716 |
19 | PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients | Cancer Cell | 2004 | 1,711 |
20 | The Human Cell Atlas | ELife | 2017 | 1,677 |
21 | Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2 | Journal of Clinical Oncology | 2004 | 1,672 |
22 | Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1 | Journal of Clinical Oncology | 2004 | 1,669 |
23 | Bile leakage after hepatobiliary and pancreatic surgery: A definition and grading of severity by the International Study Group of Liver Surgery | Surgery | 2011 | 1,666 |
24 | VEGF-targeted therapy: mechanisms of anti-tumour activity | Nature Reviews Cancer | 2008 | 1,587 |
25 | Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia | New England Journal of Medicine | 2020 | 1,577 |
26 | Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation | New England Journal of Medicine | 2018 | 1,571 |
27 | Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases | Annals of Surgery | 2004 | 1,569 |
28 | Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation | Journal of Clinical Oncology | 2009 | 1,532 |
29 | Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors | New England Journal of Medicine | 2014 | 1,518 |
30 | Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition | Nature Cell Biology | 2004 | 1,475 |
31 | Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer | New England Journal of Medicine | 2016 | 1,465 |
32 | Incidence Proportions of Brain Metastases in Patients Diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System | Journal of Clinical Oncology | 2004 | 1,463 |
33 | Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial | Lancet Oncology, The | 2017 | 1,434 |
34 | Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung Cancer | Journal of Clinical Oncology | 2006 | 1,433 |
35 | Pigment Epithelium-Derived Factor: A Potent Inhibitor of Angiogenesis | Science | 1999 | 1,425 |
36 | Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia | Blood | 2006 | 1,423 |
37 | TRIBUTE: A Phase III Trial of Erlotinib Hydrochloride (OSI-774) Combined With Carboplatin and Paclitaxel Chemotherapy in Advanced Non–Small-Cell Lung Cancer | Journal of Clinical Oncology | 2005 | 1,420 |
38 | Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib | Journal of Clinical Oncology | 2005 | 1,409 |
39 | Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer | Journal of Clinical Oncology | 2010 | 1,398 |
40 | Correlation of Computed Tomography and Positron Emission Tomography in Patients With Metastatic Gastrointestinal Stromal Tumor Treated at a Single Institution With Imatinib Mesylate: Proposal of New Computed Tomography Response Criteria | Journal of Clinical Oncology | 2007 | 1,373 |
41 | Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer | New England Journal of Medicine | 2018 | 1,356 |
42 | Guidelines for Perioperative Care in Elective Colorectal Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations: 2018 | World Journal of Surgery | 2019 | 1,307 |
43 | Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens | Journal of Clinical Oncology | 2000 | 1,305 |
44 | Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial | International Journal of Radiation Oncology Biology Physics | 2002 | 1,298 |
45 | Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy | Journal of Clinical Oncology | 2007 | 1,294 |
46 | Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis | JAMA - Journal of the American Medical Association | 2017 | 1,272 |
47 | Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck | New England Journal of Medicine | 1990 | 1,260 |
48 | Chemotherapy Regimen Predicts Steatohepatitis and an Increase in 90-Day Mortality After Surgery for Hepatic Colorectal Metastases | Journal of Clinical Oncology | 2006 | 1,211 |
49 | Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy | Journal of Clinical Oncology | 1999 | 1,208 |
50 | Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer | Journal of Clinical Oncology | 2003 | 1,206 |